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Abstract. We introduce a method for quantitative hyperspectral optical imaging in the spatial frequency domain
(hs-SFDI) to image tissue absorption (μa) and reduced scattering (μ 0s) parameters over a broad spectral range.
The hs-SFDI utilizes principles of spatial scanning of the spectrally dispersed output of a supercontinuum laser
that is sinusoidally projected onto the tissue using a digital micromirror device. A scientific complementary metal–
oxide–semiconductor camera is used for capturing images that are demodulated and analyzed using SFDI com-
putational models. The hs-SFDI performance is validated using tissue-simulating phantoms over a range of μa
and μ 0s values. Quantitative hs-SFDI images are obtained from an ex-vivo beef sample to spatially resolve con-
centrations of oxy-, deoxy-, and met-hemoglobin, as well as water and fat fractions. Our results demonstrate that
the hs-SFDI can quantitatively image tissue optical properties with 1000 spectral bins in the 580- to 950-nm
range over a wide, scalable field of view. With an average accuracy of 6.7% and 12.3% in μa and μ 0s, respectively,
compared to conventional methods, hs-SFDI offers a promising approach for quantitative hyperspectral tissue
optical imaging. © The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this
work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.24.7.071614]
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1 Introduction
Biomedical hyperspectral imaging (HSI) combines high-resolu-
tion spectral and spatial content, in order to characterize tissue
structure and composition. Because HSI typically employs hun-
dreds or thousands of optical wavelengths, multiple endogenous
and exogenous tissue components with unique spectral signa-
tures can be resolved. Various HSI technical approaches have
been developed for biomedical applications—most based on
designs that generate reflectance and/or fluorescence maps over
a continuous spectral bandwidth.1–3 Hyperspectral content can
be used in conjunction with computational models of light trans-
port and various statistical methods, such as principal compo-
nent analysis, to calculate optical and physiological
properties for each pixel.4–6 However, these methods generally
require assumptions or approximations about certain tissue fea-
tures, such as scattering properties and water concentration.7,8
Unlike temporally or spatially resolved approaches, they do not
independently separate and map subsurface tissue absorption
and reduced scattering parameters, μa and μ 0s, respectively, for
each wavelength and pixel.9 Changes in each of these parame-
ters occur with spatial and temporal variations in tissue molecu-
lar composition and structure. As a result, quantitatively
characterizing these light–tissue interactions over a broad spec-
tral range with high temporal resolution can be important in
accurately recovering dynamics of multiple endogenous and
exogenous tissue chromophores.10,11
Spatial frequency domain imaging (SFDI) is a wide-field,
noncontact, model-based technique that quantitatively separates
light absorption from scattering on a pixel-by-pixel basis by cal-
culating the modulation transfer function of structured light pro-
jected onto the tissue.12 SFDI has been used extensively to
characterize the optical and physiological properties of tissue
and visualize quantitative maps of tissue oxy/deoxyhemoglobin
concentrations, both in-vivo and ex-vivo.13–15 Hyperspectral
SFDI methods were first introduced using a liquid crystal tun-
able filter (LCTF) in conjunction with an imaging camera and a
conventional broadband source in order to serially acquire
hyperspectral maps of tissue μa and μ 0s.
16 This system can gen-
erate hyperspectral content that is limited by the speed and spec-
tral performance features of the LCTF. Hyperspectral SFDI has
also been developed using a single snapshot imager to character-
ize mouse brain,17 and has been combined with a hyperspectral
line-scan camera to track brain tumor drug delivery in a rat
model.18
More common SFDI approaches employ multiple discrete
light sources combined time-sharing schemes for acquiring
spectral content.19 These methods gain speed by sacrificing
spectral content and typically employ a limited number of wave-
lengths, e.g., 2 to 10. However, with the development of real-
time SFDI methods using square waves and fixed pattern pro-
jection combined with innovative image demodulation strate-
gies,20–22 spatial frequency modulation no longer imposes an
imaging speed/informatics bottleneck. As a result, new SFDI
strategies for increasing spectral content have been introduced
using temporally encoded light sources23 and single-pixel com-
pressive sensing.24 To maximize information content from tis-
sues, these methods should provide sufficient bandwidth and
resolution to probe multiple endogenous and exogenous chro-
mophores simultaneously, typically in the 100 to 200 nm band-
width range, with resolution that is on the order of 5 to 10 nm. In*Address all correspondence to Bruce J. Tromberg, E-mail: bjtrombe@uci.edu
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addition, for characterizing endogenous tissue components,
spectral regions with high-value information content can span
broadly from the visible to the near-infrared (NIR), which puts
significant demands on strategies for achieving quantitative
hyperspectral content.
In this work we seek to significantly expand spectral content
using a single supercontinuum laser to obtain broadband images
distributed into 1000 spectral bins from 580 to 950 nm over a
4 cm × 6 cm field of view (FOV). Wavelength-tunability is
achieved using dispersive optics and a scannable slit. A digital
micromirror device (DMD) is employed in pulse width modu-
lation (PWM) mode for three-phase sinusoidal projection.
Images are formed using a high-speed scientific complementary
metal–oxide–semiconductor (sCMOS) camera that sequentially
captures one spatial slice (x; y) of a spectral data cube while con-
tinuously sweeping through all wavelengths (λ). Similar
approaches for supercontinuum spectral selection have been
introduced previously using both temporal encoding of spectral
bins25 and spatial filtering.26,27 The exposure time for the camera
in the internal running mode and the translation speed of the slit
results in 1000 image captures across the spectrum. To decouple
the contributions of the chromophores of interest, however, 5- to
10-nm spectral intervals are sufficient. Therefore, we used only
208 spectral bins for optical property calculations in this paper.
Acquiring 1000 spectral bins in a broad bandwidth, however,
gives the ability to capture absorption signatures and dynamics
of chromophores without presumption on their existence in the
sample. An example can be the breakdown of hemoglobin in
burn wounds by observing temporal evolution of absorption
spectra.28 Another example is temperature-dependent changes
in NIR water absorption spectra.29
We assessed the hs-SFDI performance by measuring tissue
phantoms over a range of optical absorption and reduced scat-
tering values and then compared the results with a commercial
SFDI instrument and spectrophotometer data. Our results show
that hs-SFDI can be used to quantitatively image tissue absorp-
tion and scattering properties and provide spectral fingerprints
of multiple chromophores including oxy- deoxy- and met-
hemoglobin, as well as tissue water and fat. These parameters
are clinically useful and can be incorporated in applications such
as burn wound and diabetic foot ulcer assessments,30,31 as well
as imaging hemodynamics and microvascular function in dis-
eases where tissue composition, blood flow, and metabolism are
compromised.32
2 Materials and Methods
2.1 Hyperspectral SFDI Instrument
The hyperspectral SFDI system is based on a 5-ps diode pumped
Yb fiber laser supercontinuum source (SC 400-2, Fianium,
United Kingdom). Once spectrally broadened, the source gen-
erates picosecond pulses with a broadband spectrum of 400 to
2100 nm at a maximum total power of 2W. Bandpass filtering of
the broadband laser source is achieved by utilizing a folded
prism Martinez compressor design. A prism (PS858,
Thorlabs, Newton, New Jersey) spatially disperses the illumina-
tion beam on a Plössl lens.33 The Plössl lens brings the illumi-
nation beam to a line focus onto a slit (VA100, Thorlabs,
Newton, New Jersey), which is mounted on a linear stage
(TLS13E, Zaber Technologies Inc., Vancouver, British
Columbia), in front of a mirror to fold the design to be more
compact. This configuration allows for tuning the spectral
bandwidth and central wavelength of the broadband laser out-
put. The Plössl lens is moved down from the optical axis to steer
the beam so that it can be easily picked off with a D-mirror after
the second pass through the prism. The Plössl lens consists of
two achromatic doublet lenses in a symmetrical placement. This
configuration ensures a flat-field curvature for the entire line
focus where the slit selects the spectral output. The flat-field
curvature then helps proper collimation of beam once spectrally
selected. Another advantage of the Plössl lens is to help mitigate
chromatic aberration.
The wavelength-tuned beam is then expanded. To reduce
spatial heterogeneity, the beam is transmitted through a high grit
diffuser (DG100-600-B, Thorlabs, Newton, New Jersey) prior to
the DMD (CEL5500, Digital Light Innovation, Austin, Texas).
The DMD produces 8-bit grayscale sinusoidal patterns through
the time-sharing PWM method. The spatially modulated light is
imaged onto the sample and the diffusely reflected light is cap-
tured via a high-speed sCMOS camera (ORCA-Flash 4.0 V2,
Hamamatsu Photonics K.K., Japan). To increase the signal-
to-noise ratio (SNR), pixels are binned by a factor of 4, which
gives an image resolution of 512 × 512 pixels over a
4 cm × 6 cm FOV. The camera captures images using the inter-
nal running mode to achieve highest acquisition rate at a con-
stant exposure time, 50 ms, which is adjusted to the pattern
refresh rate of the DMD. The proposed setup has the flexibility
to optimize light throughput by adjusting slit speed and camera
integration time.
The start and end locations of the motorized stage are chosen
with margins to allow for cruising at constant speed within the
desired spectral range, 580 to 950 nm. The camera and DMD are
controlled by trigger signals from the stage via Arduino Due
microcontroller (Sparkfun Electronics, Niwot, Colorado) once
the slit reaches both ends of the spectrum. Each scan of the mov-
ing slit provides 1000 images. A schematic of the instrument is
shown in Fig. 1(a).
2.2 Spectral Characterization
Figure 1(b) shows a plot of slit location as a function of wave-
length. Intensity profile across the spectrum is also shown with a
peak intensity at 740 nm. We chose 1000 slit locations corre-
sponding to 1000 spectral bins in the 580- to 950-nm region
and measured the output spectra using a spectrometer (Blue
Wave, Stellar Net Inc., Tampa, Florida). Slit width was set to
200 μm. Mean and standard deviation (SD) of full width at half
maximum (FWHM) was calculated to be 17.25 and 5.69 nm,
respectively. As expected, lower dn∕dλ (n, refractive index of
prism material; λ, Wavelength) at longer wavelengths on the dis-
persive prism led to increasing spectral bandwidth, reaching
26.42 nm for the 950-nm spectral bin.
Most of the spectral features of the tissue main chromophores
(oxy/deoxy/methemoglobin, fat, and water) in the first optical
window (600 to 1000 nm) are broader than the instrument band-
width using the hs-SFDI instrument.
2.3 SFDI Processing
In this paper, we have used a single spatial frequency
(fx ¼ 0.1 mm−1) sinusoidal pattern at three 2π∕3 rad-shifted
phases, which were then inserted into the following SFDI
demodulation Eq. (1):
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EQ-TARGET;temp:intralink-;e001;63;463
ACðx; yÞ ¼ 2
1∕2
3
f½I0 degðx; yÞ − I120 degðx; yÞ2
þ ½I120 degðx; yÞ − I240 degðx; yÞ2
þ ½I240 degðx; yÞ − I0 degðx; yÞ2g1∕2; (1)
where ACðx; yÞ is demodulated reflectance at pixel (x; y) and
Iθðx; yÞ is the intensity of phase θ at pixel (x; y). The DC
demodulated reflectance is acquired by averaging over phase-
shifted single frequency images [Eq. (2)]
EQ-TARGET;temp:intralink-;e002;63;351DCðx; yÞ ¼ 1
3
½I0 degðx; yÞ þ I120 degðx; yÞ þ I240 degðx; yÞ:
(2)
The following procedure is then performed to calculate the
optical properties of a sample.
1. Demodulated AC and DC images are calculated for a
calibration phantom using the hs-SFDI instrument.
2. The calibration phantom construction is fully
described in Refs. 12, 34, and 35. Briefly, a solid sil-
icone-based tissue phantom is made with titanium(IV)
oxide (TiO2) as scattering and India ink as absorptive
agents. Thin samples of the calibration phantom are
measured via inverse adding doubling (IAD)
technique36 to characterize the wavelength-dependent
optical properties.
3. A forward Monte Carlo (MC) simulation of radiative
transport in turbid media is performed using previ-
ously acquired optical properties and true diffuse
reflectance values are calculated for both AC and
DC components.
4. The sample’s AC and DC components are divided by
their calibration images and are multiplied by the MC-
derived diffuse reflectance values to correct for instru-
ment response and to calculate absolute diffuse reflec-
tance values of the sample.
5. AC- and DC-calibrated reflectance values are finally
inserted to an inverse MC solver to extract a unique
pair of optical properties (absorption and reduced scat-
tering). We used a lookup table derived from white
MC simulations.12,37 The acceptance angle of the cam-
era was considered in the SFDI model and a Henyey
Greenstein phase function was used. The refractive
index is set to 1.4 for the beef and 1.33 for phantom
measurements. The SFDI model used for this paper is
based on volume scattering and does not account for
surface scattering of the sample. However, it has been
shown that decoupling of volume and surface scatter-
ing from reflectance data can be accomplished via a
modified solution of the radiative transfer equation. 38
3 Results
3.1 Multiconcentration Liquid Phantom
To experimentally validate the performance of the broadband
hyperspectral imager, we performed a series of controlled tissue
phantom measurements to demonstrate that the instrument can
quantify absorption and reduced scattering over a wide spectral
range. Solid tissue phantoms were fabricated from silicone, as
described in Sec. 2.3. We then inserted 12.5-mm diameter cylin-
drical molds in the base phantom. Once the base phantom was
cured, we removed the cylindrical molds and poured the liquid
solutions in the resulting “wells.” A schematic of the tissue
phantom is shown in Fig. 1(a).
(a) (b)
Fig. 1 (a) Schematic representation of the hs-SFDI instrument and tissue phantom: supercontinuum
input is first dispersed via a prism and imaged onto a mirror placed at the focal point of a cylindrical
lens. A slit mounted on a linear stage selects the spectral output, which is spatially modulated via a
DMD and projected onto the tissue phantom. The tissue phantom is made of solid silicone background
with four wells that are filled with solutions of absorptive dyes and IL. (b) Slit location-central wavelength
plot. Each slit location of the hs-SFDI instrument corresponds to a tuned spectral bin from the broadband
source. Spectral bins aremeasured using a spectrometer and are shown with color-coded sensor counts.
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Distilled water-based solutions of Naphthol Green B at
multiple concentrations [0.25, 0.03125, 0.0375, 0.04275, and
0.05 gram per liter (g/L)] were prepared and measured with a
custom-built spectrophotometer to calculate the absorption coef-
ficients from 580 to 950 nm. Turbid versions of the same sol-
utions were prepared by adding intralipid (IL) (Fresenius Kabi,
Uppsala, Sweden): one milliliter (mL) of 20% IL was added to
19 mL of each solution, poured into the wells of the phantom,
and measured with the hyperspectral SFDI instrument. The
measurement was performed over 1000 spectral bins in the
580- to 950-nm region; however, we selected 208 linearly
spaced bins for our final analysis.
Figure 2(a) shows absorption coefficient values of 5
Naphthol Green B solutions determined using the hyperspectral
SFDI instrument and the spectrophotometer. The μa values of
these solutions range from 0.015 to 0.087 mm−1, whereas μ 0s
range from 0.75 to 1.8 mm−1. Figure 2(b) shows reduced scat-
tering plots for the five solutions. The optical properties in Fig. 2
are determined by averaging over a 6 mm × 6 mm region of
interest (ROI) in the center of each well. Average standard devi-
ations in absorption and reduced scattering maps of these ROIs
are 0.0019 and 0.0488 mm−1, which give coefficients of varia-
tion of 3.949% and 3.614%, respectively.
The average difference between recovered μa values deter-
mined using the hs-SFDI instrument and spectrophotometer val-
ues was 6.7% (SD 6.8%). We expected similar μ 0s values for
these solutions since the dominant scattering contribution origi-
nated from their comparable IL concentrations. We showed that
the hs-SFDI-fitted μ 0s values were within 12.3% (SD 6.9%) of
1% IL μ 0s values measured by a conventional SFDI instrument.
A commercially available SFDI measurement system, Reflect
RS™ (Modulated Imaging, Inc., Irvine, California), was used
to image reduced scattering coefficients of 1% IL solutions at
six wavelengths between 580 and 850 nm. We then fitted a
power series to 6 data points and compared Reflect RS™ reduced
scattering values with hs-SFDI data at 208 spectral bins in the
580- to 950-nm region.
Although there is larger error in scattering at short wave-
lengths, the fact that precision of scattering spectra for different
dye concentrations is acceptable (1% to 2.5% coefficient of
variation in the 680- to 950-nm range) implies that there may
be systematic errors that cause this discrepancy. One of our sus-
picions is the chromatic aberration on the h-SFDI setup, which
can add more “blurring” to the fringes, thus jeopardizing the
SFDI algorithm to report higher scattering values.
Figure 3(a) shows fit intervals for the expected μa values,
spectrophotometer results, and those obtained using the hs-
SFDI instrument for all five solutions at 208 wavelengths.
Figure 3(b) shows Bland–Altman plots39 of recovered optical
absorption for the same data set. About 94% of hs-SFDI mea-
surements are within 1.96 × SD of the mean difference indicat-
ing a close agreement between the two approaches. The data
points with errors larger than 1.96 × SD are more significant for
absorption coefficients <0.02 mm−1, specifically for wave-
lengths longer than 750 nm, where the bandwidth of spectral
bins becomes larger due to lower dn∕dλ imposed by the disper-
sive prism in our optical design. However, other factors, such as
the partial volume effect from the surrounding medium at lower
absorption values and low SNR at longer wavelengths, could
also contribute to this result. Figure 3(c) shows fit intervals for
the expected μ 0s values from Reflect RS
™ and hs-SFDI results for
the five solutions at 208 wavelengths. Figure 3(d) shows Bland–
Altman plots of recovered reduced scattering.
3.2 Multidye Phantom
To test spectral resolution, solutions of four compounds with
absorption peaks at 636, 675/930, 730, and 910 nm were fab-
ricated: blue food dye (Ateco, Glen Cove, New York), extra
virgin olive oil, Naphthol Green B (Sigma Aldrich, St. Louis,
Missouri), and FHI96716 dye (Fabricolor Holding Int’l,
Paterson, New Jersey), respectively. We then made turbid ver-
sions of these solutions by adding 20% IL so that the resulting
concentrations of IL were 1%, except for the olive oil, which
Fig. 2 (a) Plot of bulk μa spectra for five concentrations of Naphthol Green B in 1% IL. Each data point
corresponds to the mean value of μa over a 6 mm × 6 mm ROI. About 208 data points in the 580- to 950-
nm region are plotted for each concentration. Colored lines are from the hs-SFDI instrument and black
dashed lines are spectrophotometer measurements. Mean spatial standard deviation of hs-SFDI-derived
μa values over specified ROIs is 0.0019 mm−1. (b) Plot of bulk μ 0s spectra for five concentrations of
Naphthol Green B solutions in 1% IL. The hs-SFDI reduced scattering values are compared to those
obtained using a conventional SFDI instrument, Reflect RS™. Mean standard deviation of hs-SFDI-
derived μ 0s values over specified ROIs is 0.0488 mm−1.
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was mixed with TiO2. The four solutions were then poured in
wells of a silicone phantom built using the same method
described in Sec. 3.1. The concentrations of Naphthol Green
B solutions were chosen to be within the range of brain and skin
tissues commonly measured with SFDI.28,40 Also, at lower
absorption values, there are limitations with accuracy of IAD.
Therefore, in this study we measured phantoms in the absorption
range where our calibration technique provided reliable values.
We measured these solutions using the hs-SFDI instrument
and extract μa and μ 0s for 1000 spectral bins in the 580- to 950-
nm range. Figure 4 shows absorption spectra for the four sol-
utions. The optical properties are determined by averaging over
a 6 mm × 6 mm ROI in the center of each well. The spectral
shapes of these solutions agree with the expected absorption
spectra trends for each. There is, however, some cross talk
between the FHI96716 sample and the calibration phantom
in the 890- to 910-nm region. The calibration phantom has
an absorption peak in the 910-nm region that is consistent with
the absorption of silicone. The contribution of the 910-nm peak
is visible in the absorption spectra of the sample. Therefore, the
calibration procedure, discussed in Sec. 2.3, has not completely
corrected for instrument response and absorption features of the
calibration phantom.
On the scattering values, however, there were increased devi-
ations in reduced scattering values between the three solutions
with 1% IL concentrations, compared to Sec. 3.1. This could be
related to photons propagating through multiple media in the
phantom with different refractive indices and optical properties
or minor spatial variations in the calibrated reflectance.
Therefore, scattering plot is not presented in this section.
Fig. 3 (a) Comparison between absorption coefficients extracted from spectrophotometer (expected μa)
and hs-SFDI (measured μa). Scatter plot with regression fit and confidence intervals for slope and fit.
(b) Bland–Altman plots of mean and percentage difference between spectrophotometer (expected
μa) and hs-SFDI data (measured μa). Dashed lines show intervals forþ∕ − 1.96 times standard deviation
of percentage difference. The absorption percentage differences are calculated by using the spectropho-
tometer values in the denominator. (c) Comparison between fitted reduced scattering coefficients
extracted from Reflect RS™ (expected μ 0s) and hs-SFDI (measured μ 0s). Scatter plot with regression fit
and confidence intervals for slope and fit. (d) Bland–Altman plots of mean and percentage difference
between Reflect RS™ (expected μ 0s) and hs-SFDI data (measured μ 0s). Dashed lines show intervals for
þ∕ − 1.96 times standard deviation of percentage difference. The reduced scattering percentage
differences are calculated by using the fitted Reflect RS™ values in the denominator.
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Figure 5 shows a movie of the spectral cube (x; y, and λ) for
absorption and reduced scattering coefficients of the multiwell
phantom. While averaging over the center of each well gives a
bulk optical property value, there are partial volume effects next
to the edges as large path lengths allow photons from the solid
medium to enter each well and contribute to the localization of
optical properties.
3.3 Beef Sample
To characterize a more realistic biological specimen, we mea-
sure a sirloin beef sample with distinct regions of the primary
tissue chromophores: hemoglobin, water, and lipid. Figure 6
shows absorption and reduced scattering spectra for two
3 mm × 3 mm (15 pixels × 15 pixels) ROIs located on the fatty
and muscle part of the sample. ROIs are chosen on smooth areas
of the sample to avoid artifacts from very steep angles.
The absorption spectra have local maxima, as shown in
Fig. 6(a), at 600 and 630 nm mostly due to deoxy/oxyhemoglo-
bin and methemoglobin absorption, respectively. These peaks
are noticeable for both ROIs since the diffuse light field samples
a larger volume than the specified ROI and there is spatial
heterogeneity in three dimensions (i.e., partial volume effect).
An increase in absorption values at 850 nm and longer wave-
lengths is seen in both fatty and muscle components. There
is also a distinct lipid absorption peak at about 920 nm in the
spectrum acquired from the fat ROI. The overall trend and mag-
nitude of absorption and reduced scattering spectra on the
muscle ROI agree with previous studies.41,42 The fat ROI μ 0s val-
ues are consistently greater than muscle and, when fitted to a
standard Mie theory model:43 μ 0s_normalized ¼ A × ðλ∕850 nmÞ−b,
scattering prefactor (A), and scattering power (b) are, respec-
tively, 1.259 mm−1 and 1.043 for fatty tissue and 0.5051 mm−1
and 1.248, for muscle tissue. These values are comparable with
previous reports in Ref. 44 as average (standard deviation) of A
and b parameters for fatty tissue from six studies are 1.288
ð0.630Þ mm−1 and 0.672(0.242), respectively. The average
(standard deviation) of A and b parameters of muscle/heart
tissue from four studies are 0.531 ð0.224Þ mm−1 and 1.609
(0.722), respectively.
Figure 7 shows absorption and reduced scattering maps at
two wavelengths (600 and 930 nm).
Finally, we fitted the absorption spectra at two 3 mm × 3 mm
(15 pixels × 15 pixels) ROIs (fat and muscle regions) to five
chromophores: oxyhemoglobin (HbO2), deoxyhemoglobin (Hb),
methemoglobin (MetHb), fat, and water using the Beer–Lambert
law, published extinction coefficient values,45 and MATLAB
(Mathworks Inc., Natick, Massachusetts) linear least-squares
solver. Table 1 shows calculated values and standard deviations
for each chromophore.
The calculated values match with expected higher hemoglo-
bin concentrations and water fraction in the muscle. Overlap of
MetHb with fat and water absorption peaks and the large band-
width of spectral bins in the 850- to 950-nm region decrease our
ability to fully decouple these chromophores, thus causing a
possible underestimation of MetHb and an overestimation of fat
in the muscle ROI. We exclude spectral bins in the 580- to 600-
nm region in the chromophore fitting procedure due to low SNR
imposed by hemoglobin absorption in the sample. In general,
there are many issues including type of skeletal muscle, date
of harvesting, packaging, and the aging procedure that can cause
variations in the sample’s constituents. Depth of interrogation
also differs across the spectral bandwidth, which can prevent
sampling the same volume of tissue. Full control over these
parameters is out of the scope of this study but may allow for
more accurate estimation of tissue constituents.
4 Discussion
In this paper, we introduce a design for quantitative, hyperspec-
tral SFDI of tissue optical properties over a broad range of opti-
cal wavelengths. One of the challenges with our current
wavelength-tuning configuration is acquisition speed. It takes
about 150 s to acquire a hyperspectral cube using conventional
three-phase sinusoidal projection since the slit scans a 6.3-mm
line at 0.1 mm/s; equivalent to a total bandwidth of 370 nm. In
principle, the scanning slit can move at a maximum speed of
6.5 mm/s, which enables it to cover the entire bandwidth in less
than a second and 3 s for a total of three phases. However, at our
current large FOV (4 cm × 6 cm), this requires a much higher
sinusoidal pattern refresh rate on the DMD and lower exposure
times on the camera, which are not possible with the current
components.
Fig. 4 Plot of bulk μa spectra for four solutions: three water-soluble
dyes with 1% IL concentration. Olive oil is mixed with known concen-
tration of TiO2 (0.65 g/L). Each data point corresponds to the mean
value of an optical property over a 6 mm × 6 mmROI. About 208 data
points in the 580- to 950-nm region are plotted for each concentration.
Fig. 5 Spectral cube (x; y , and λ) for absorption and reduced scatter-
ing coefficients of the multiwell phantom. Schematic representation of
the wells with the silicone-based solid background is shown (Windows
Media Player, 782 KB).
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One solution we have introduced that overcomes this refresh
rate limitation of the DMD is to employ square waves rather
than sinusoidal patterns. The 8-bit sinusoidal refresh rate on the
current DMD is 60 Hz. This increases to 5 kHz for binary square
wave patterns. This approach has been utilized in a video-rate
multispectral SFDI instrument to track hemodynamics in a pre-
clinical rat model of cardiac arrest and resuscitation.46 In
addition, square pattern illumination can synthesize multiple
spatial frequency components (fundamental and harmonic) to
probe multiple depths.21 In the case of homogeneous samples,
using diffuse reflectance values at multiple spatial frequencies
can also help minimize μa and μ 0s fitting errors.
47 The alternative
solution would be single snapshot techniques, which do not
require three phase projections.48 However, these techniques
Fig. 6 Plot of (a) bulk μa spectra and (b) μ 0s spectra at two ROIs (3 mm × 3 mm): fat (red) and muscle
(blue).
Fig. 7 (a), (b) The μa and (c), (d) μ 0s maps of the beef sample at 600 and 930 nm. The dominant spatial
contrast between fat and muscle arises from oxy/deoxyhemoglobin absorption at 600 nmwhile increases
in both lipid and water absorption at 930 nm reduces absorption contrast between these components.
Higher A and lower b parameters in the fat region cause decrease in contrast between the fat and muscle
regions in the reduced scattering map. Also, at longer NIR wavelengths, higher scattering-to-absorption
ratios and therefore partial volume effect cause lower spatial resolution.
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require a large number of cycles in the modulation pattern to
mitigate ringing artifacts and may not be applicable to small
FOVs.22
Choosing an optimized exposure time of the camera is
mainly dependent on total light throughput, power distribution
on both tails of the spectral bandwidth, and sensitivity of the
camera sensor. When exposure time is set to a constant value
for all spectral bins, diffuse reflectance of a 1% absorbing
material (Spectralon, Lab Sphere, North Sutton, New
Hampshire) shows a peak at 740 nm. Total number of counts
on the sensor then decreases up to 4.5-fold for both tails of the
spectra at 580 and 950 nm. Therefore, exposure time at spectral
bins with lower throughput needs to be increased to enhance
SNR. It is worth mentioning that refresh rate of the DMD needs
to be adjusted accordingly in the case of sinusoidal illumination.
Another optimization step can involve replacing the diffuser,
which was installed to homogenize the beam profile with a
higher throughput light pipe homogenizing rod (48-582,
Edmund Optics, Barrington, New Jersey). The quantum effi-
ciency of the camera at wavelengths longer than 900 nm is
below 25% as compared to 82% at around 580 nm. All the
lenses in the proposed optical configuration have antireflection
coating in the 650- to 1000-nm range. Achieving high SNR at
wavelengths longer than 900 nm can be important for decou-
pling the absorption contribution of fat and water in biological
tissue, which have peaks at 930 and 970 nm, respectively.
Despite the limitations, our slit-scanning approach provides
flexibility in selecting the bandwidth and central wavelength of
supercontinuum source even outside our current operating spec-
tral range, 580 to 950 nm, e.g., short-wave infrared (900 to
1700 nm). However, the slit-scanning decreases a large portion
of light throughput by passing the input beam through multiple
lenses. Alternate wavelength-tuning approach is to integrate an
acousto-optic tunable filter to the light path for rapid wavelength
selection.
5 Conclusion
We have demonstrated the integration of a versatile wavelength-
tuning configuration for a supercontinuum laser-based projec-
tion unit for a hyperspectral SFDI instrument that records tissue
optical properties over 1000 wavelength bands (from 580 to
950 nm). We validated the performance of the hs-SFDI instru-
ment to quantity and decouple optical properties, absorption,
and reduced scattering, in a range of tissue-simulating phan-
toms, by comparing absorption values to spectrophotometer
measurements. Average absorption values were within 6.7%
of the spectrophotometer data. Reduced scattering coefficients
were within 12.3% of those obtained using a conventional
SFDI instrument. The effects of spectral range and resolution
were shown by measuring a tissue phantom consisting of four
wells with distinct spectral signatures. We also performed an ex-
vivo measurement of a beef sample to quantify and spatially
resolve spectral fingerprints of a variety of tissue-containing
molecules such as oxy-, deoxy-, and met-hemoglobin, as well
as water and fat.
While there are challenges in accelerating image acquisition
on the hs-SFDI system, techniques such as integration with sin-
gle-pixel SFDI techniques,24 encoding hyperspectral informa-
tion in the illumination beam via light labeling,25,49 and
acousto-optic tunable filters have potential to resolve the spec-
tral-temporal performance trade-off.
Despite these challenges, our study provides a platform to
characterize and localize tissue structure and constituents with
millimeter spatial resolution over a scalable FOV using quanti-
tative continuous hyperspectral optical-property content.
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